Your browser doesn't support javascript.
loading
Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
Liu, Lei; Li, Yaping; Tang, Shiying; Yang, Bin; Zhang, Qiming; Xiao, Ruotao; Hou, Xiaofei; Liu, Cheng; Ma, Lulin.
Afiliação
  • Liu L; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Li Y; Department of Medicine, Acornmed Biotechnology Co., Ltd, Beijing, China.
  • Tang S; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Yang B; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Zhang Q; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Xiao R; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Hou X; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Liu C; Department of Urology, Peking University Third Hospital, Beijing, China.
  • Ma L; Department of Urology, Peking University Third Hospital, Beijing, China.
Int J Biol Markers ; 38(2): 114-123, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37192745

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article